Executive Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Executive Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$73.27 - $83.09 $4,909 - $5,567	-67 Reduced 2.49%	2,622 $212,000
Q3 2023 Nov 07, 2023	SELL	$73.94 - $80.67 $10,499 - $11,455	-142 Reduced 5.02%	2,689 $201,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $2,052 - $2,340	27 Added 0.96%	2,831 $218,000
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $850 - $968	11 Added 0.39%	2,804 $232,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $174,059 - $249,889	2,793 New	2,793 $239,000
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $6,000 - $6,624	-96 Reduced 16.16%	498 $31,000
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $309 - $346	5 Added 0.85%	594 $40,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $59,778 - $66,967	-956 Reduced 61.88%	589 $38,000
Q4 2018 Feb 19, 2019	BUY	$60.54 - $79.0 $93,534 - $122,055	1,545 New	1,545 $97,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Executive Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Executive Wealth Management, LLC with notifications on news.